Medical Devices Leader Series: Top In Vitro Diagnostics (IVD) Companies 2017-2027
LONDON, November 23, 2016 /PRNewswire/ --
Leading IVD Companies in the US, Europe and Asia
What does the future hold for companies of the in vitro diagnostics (IVD) industry? Visiongain's new report Medical Devices Leader Series - Top In Vitro Diagnostics (IVD) Companies 2017-2027: Leading IVD Companies in the US, Europe and Asia shows you the prospects of leading IVD companies to 2027.
Visiongain predicts total revenues the global IVD market will grow from its 2016 level of $61.85bn to $122.9bn by 2027, representing a CAGR of 6.4% during the period 2016 to 2027.
Our report forecasts to 2027 the overarching IVD market and its main segments:
• Point-of-care (POC) tests
• Clinical chemistry
• Immunochemistry
• Haematological diagnostics
• Microbiological applications
• Genetic testing agents
• Other products
This report provides profiles, discussions and financial analyses - including revenue forecasts to 2027 - for top US IVD companies:
• Danaher
• Abbott Laboratories
• Johnson & Johnson (J&J)
• Bio-Rad
• Becton Dickinson
• Thermo Fisher Scientific
Our report shows you developments and revenue forecasts to 2027 for leading diagnostics companies based in Europe:
• Roche
• Siemens
• bioMérieux
This report also provides outlooks and revenue forecasts to 2027 for top Japanesecompanies developing and producing IVD tests:
• Sysmex
• Arkray
To see a report overview please email Sara Peerun on sara.peerun@visiongainglobal.com
Our work assesses other companies progressing in that field. There you discover activities of these emerging players and their associated organisations:
• Dako (Agilent Technologies)
• Genomic Health
• Laboratory Corporation of America (LabCorp)
• MDxHealth
• Myriad Genetics
• QIAGEN
Our 185 page report provides 65 tables and 75 figures covering 7 different IVD submarkets, leading companies in the US, Europe and Asia.
Discover the most lucrative areas in the industry and the future market prospects. You will see financial results, industry trends, opportunities, and revenue predictions. The increasing prevalence of both chronic and infectious diseases will ensure that there is a great demand for use and innovation of IVDs over the next decade and beyond.
To request a report overview of this report please emails Sara Peerun at sara.peerun@visiongainglobal.com or call Tel: +44 (0) 20 7336 6100
List of Companies and Organisation
3M
AB Sciex
Abbott Laboratories
AbbVie
Accuri Cytometers
Agilent Technologies
Alacris Theranostics GmbH
Alere
Amgen
Analytical Technologies
ARGENE
Arkray
AstraZeneca
Banner Alzheimer's Institute
Bayer
Bayer Diagnostics
BD Pharmaceutical Systems
BD Technologies
Beckman Coulter
Becton, Dickinson and Company (BD)
BioMarin Pharmaceutical
bioMérieux
Bio-Rad
Boehringer Ingelheim
Bristol-Myers Squibb
Cancer Research Technology
Cardiogenics
Carmel Pharma AB
Celldex Therapeutics
Cellestis
Centre for Devices and Radiological Health (CDRH)
Cephalon
Claros Diagnostics
Clearstone Central Laboratories
CLIA laboratory
Clovis
Cole-Parmer
Crescendo Bioscience
Dako (Agilent Technologies)
Danaher
Dionex
DxS (Now QIAGEN Manchester)
Eli Lilly
ESE GmbH
Euronext Brussels
European Commission
European Diagnostic Manufacturers Association (EDMA)
European Union (EU)
Explera s.r.l
Fermentas
Fisher Scientific
Food and Drug Administration (US FDA)
Fujirebio
Furuno Electric Co.
Genentech
Genomic Health
GenProbe
Genzyme Genetics
GlaxoSmithKline (GSK)
Hoffman La Roche
Hologic
Ibis Biosciences
IDEXX Laboratories
IGEN International
Illumina
Institut Pasteur
Institute Merieux
Instrumentation Labs
Ipsen
Ipsogen
JEOL Ltd.
John Hopkins University
Johnson & Johnson (J&J)
Katakura Industries
KIESTRA Lab Automation
Knome
LabCorp
Laboratory Corporation of America (LabCorp)
Leica Biosystems
Life Technologies
Luminex
Lyon Civil Hospitals
MDS
MDxHealth
Medco Health Sciences
Merck & Co.
Mindray
Miraca Life Sciences
Monogram Biosciences
Myriad Genetics
Myriad RBM
Nalgene
Newcastle University
Novartis
Oncomed
OncoMethylome
Ortho-Clinical Diagnostics
Pfizer
Phadia
Pierce Protein Research
Polymedco Inc.
QIAGEN
QuantaLife
Quest Diagnostics
Radiometer
Response Biomedical Corporation
Roche
Roche Applied Science
Saladax
Schering Plough
SDIX
Siemens Healthcare
Sirigen Group Limited
STARLIMS Technologies
Surgipath
SWOG
Sysmex Corporation
Sysmex Group
Teva Pharmaceutical Industries
Thermo Fisher Scientific
Thermo Scientific
TOA Corporation
TOA Medical Electronics
Tocagen
Tosoh
Transasia Bio Medicals
Van Andel Research Institute
Ventana
Vermillion
ViiV Healthcare
To see a report overview please email Sara Peerun on sara.peerun@visiongainglobal.com
SOURCE Visiongain Ltd
Share this article